Skip to main content
BEONE MEDICINES LTD. logo

BEONE MEDICINES LTD. — Investor Relations & Filings

Ticker · 688235 ISIN · CNE100005XT6 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 727 across all filing types
Latest filing 2024-04-26 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 688235

About BEONE MEDICINES LTD.

https://beonemedicines.com/

BEONE MEDICINES LTD. is a biopharmaceutical company focused on the research, development, and commercialization of innovative therapeutic solutions, primarily in the field of oncology. The company specializes in the discovery of targeted small molecule drugs and biologics designed to address unmet medical needs in cancer treatment. Its research and development pipeline emphasizes precision medicine, utilizing advanced molecular biology and medicinal chemistry platforms to identify novel drug candidates. BEONE MEDICINES LTD. aims to improve patient outcomes by developing high-efficacy, low-toxicity therapies that target specific genetic drivers of disease. The company maintains a strong focus on clinical-stage development and strategic collaborations to advance its portfolio of next-generation medicines.

Recent filings

Filing Released Lang Actions
百济神州有限公司董事会审计委员会2023年度履职情况报告
Audit Report / Information Classification · 95% confidence The document is titled as the "2023年度履职情况报告" (2023 Annual Performance Report) of the Board Audit Committee of 百济神州有限公司. It details the audit committee's activities, meetings, evaluations of external and internal audits, financial report reviews, internal control assessments, and overall evaluation for the year 2023. The content focuses on the audit committee's oversight and supervisory functions rather than presenting the full audited financial statements or the company's annual report itself. The document length is 3222 characters, which is relatively short and consistent with a committee report rather than a full Annual Report (10-K). It is not a certification letter or a brief announcement but a detailed report on audit committee activities. This fits the definition of an Audit Report / Information (AR) filing, which includes standalone audit reports and related audit committee reports. Therefore, the appropriate classification is AR with high confidence. FY 2023
2024-04-26 Chinese
安永华明会计师事务所（特殊普通合伙）关于百济神州有限公司2023年度募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "募集资金存放与实际使用情况的专项报告" which translates to a "Special Report on the Deposit and Actual Use of Raised Funds" for the year 2023. It includes detailed financial data about the amount of funds raised, their usage, balances, and management, as well as auditor's verification and opinions from a registered accounting firm (Ernst & Young Hua Ming). The document references regulatory guidelines related to the management and use of raised funds by listed companies and includes tables showing the use of funds in various projects. This is a specialized report focusing on the management and use of capital raised by the company, not a general annual or quarterly financial report. It is not an announcement or a brief summary but a detailed report with substantive financial data and auditor's attestation. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes, including detailed reports on the use of raised funds.
2024-04-26 Chinese
安永华明会计师事务所（特殊普通合伙）关于百济神州有限公司2023年度非经营性资金占用及其他关联资金往来情况的专项说明
Audit Report / Information Classification · 95% confidence The document is titled as a special explanation regarding non-operating fund occupation and other related party fund transactions for the year 2023 by BeiGene Ltd. It includes detailed tables summarizing these transactions and is dated April 25, 2024. The document references an audit report issued by Ernst & Young Hua Ming LLP with an unqualified opinion on the 2023 financial statements. The document is a standalone explanation and summary related to specific regulatory requirements on fund occupation and related party transactions, not the full annual report or audit report itself. It contains substantive financial data and detailed disclosures about related party transactions and fund usage, which are typically part of audit or regulatory compliance disclosures. Given the nature of the document as a special explanation with audit involvement but not the full annual report, it fits best under the category of Audit Report / Information (AR). The document length (13,453 characters) supports it being a full report rather than a brief announcement or certification. Therefore, the classification is AR with high confidence. FY 2023
2024-04-26 Chinese
安永华明会计师事务所（特殊普通合伙）关于百济神州有限公司2023年度营业收入扣除情况专项说明
Audit Report / Information Classification · 95% confidence The document is titled as a "2023年度营业收入扣除情况专项说明" which translates to "2023 Annual Special Explanation on Deduction of Operating Revenue." It is issued by 百济神州有限公司 (BeiGene Ltd.) and includes references to an audit report by Ernst & Young Hua Ming LLP dated April 25, 2024. The document discusses the deduction of operating revenue according to specific Shanghai Stock Exchange regulatory guidelines related to delisting financial indicators. It contains detailed financial data on revenue deductions for the year 2023 and includes auditor's statements confirming consistency with the audited financial statements. The document is a standalone audit-related explanation focusing on a specific financial metric (operating revenue deduction) and is not a full annual report or interim report. It is not a mere announcement or certification but contains substantive financial data and auditor's opinion on this specific matter. Therefore, it fits the category of an Audit Report / Information (AR) rather than a full Annual Report (10-K) or other categories. FY 2023
2024-04-26 Chinese
百济神州有限公司董事会审计委员会监督安永华明会计师事务所（特殊普通合伙）的履职情况报告
Audit Report / Information Classification · 95% confidence The document is a report from the Audit Committee overseeing the performance of the external auditor (Ernst & Young Hua Ming LLP) for the company's 2023 A-share financial statements audit. It details the auditor's qualifications, the audit process, communication with management, and the committee's evaluation of the auditor's independence and work quality. The document includes the auditor's unqualified opinion on the 2023 financial statements and the committee's confirmation that the financial reports fairly reflect the company's financial position and results. This is a standalone audit report and oversight information, not the full annual report or financial statements themselves. The document length is 1777 characters, which is short but contains substantive audit oversight content, not merely an announcement or certification. Therefore, it fits best under Audit Report / Information (AR). FY 2023
2024-04-26 Chinese
中国国际金融股份有限公司、高盛（中国）证券有限责任公司关于百济神州有限公司2023年度募集资金存放与使用情况的核查意见
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the 2023 annual verification of the storage and use of raised funds by 百济神州有限公司 (BeiGene Ltd.). It includes specific financial figures about the amount raised, usage, balance, and compliance with regulatory requirements. The report references regulatory approvals, audit opinions from accounting firms, and compliance with Shanghai Stock Exchange rules. The content focuses on the management and use of capital raised from an IPO and subsequent fundraising, with detailed tables and explanations. This matches the description of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document is substantive and not merely an announcement or certification, so it is not RPA or RNS. It is not an annual report (10-K), audit report (AR), or other categories. Therefore, the best classification is CAP with high confidence.
2024-04-26 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.